Prostatitis vs BPH: Inflammation, Prostate Enlargement and Urinary Symptoms

01. What Is the Difference Between Prostatitis and BPH?

BPH is not simply another name for an enlarged prostate

The terminology around BPH is often simplified in everyday conversation, but the medical distinctions are useful.

Current EAU male lower urinary tract symptom guidance separates:

• benign prostatic hyperplasia (BPH): the characteristic histological growth pattern within prostate tissue;
• benign prostatic enlargement (BPE): an increase in prostate size;
• benign prostatic obstruction (BPO): bladder outlet obstruction attributed to benign prostate enlargement.

These concepts are related, but they are not identical.

A man can have histological BPH without severe urinary symptoms. Another can have a large prostate without proportionate obstruction. A third can have troublesome lower urinary tract symptoms partly caused by the bladder rather than the prostate.

For the broader BPH pathway, see Benign Prostatic Hyperplasia and Prostate Enlargement.

What does prostatitis mean?

Prostatitis covers several clinically different prostate and pelvic-pain conditions.

The major categories include:

• acute bacterial prostatitis: a sudden bacterial infection involving the prostate;
• chronic bacterial prostatitis: persistent or recurrent bacterial infection associated with the prostate;
• chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): persistent or recurrent pelvic or prostate-region pain without a proven bacterial infection explaining the syndrome;
• asymptomatic inflammatory prostatitis: inflammation identified without the typical prostatitis symptom syndrome.

These categories are explained in more detail in Prostatitis and Prostate Pain.

Does prostatitis mean the prostate is enlarged?

No.

An acutely infected prostate can become swollen, but prostate enlargement is not the defining feature of prostatitis.

Similarly, chronic pelvic pain can be substantial even when prostate volume is not particularly large.

This is one of the most important differences from BPH-related enlargement: the severity of prostatitis pain cannot be inferred from prostate size.

Does BPH mean the prostate is inflamed?

No.

Inflammation and fibrosis may participate in the biology of BPH in some men, but BPH is not diagnosed as an inflammatory prostate disorder.

The defining pathological concept is benign hyperplastic growth.

Calling BPH “prostatitis” simply because inflammatory cells can sometimes be present would confuse two different clinical diagnoses.

02. Which Symptoms Point More Toward Prostatitis or BPH?

Why are these conditions easy to confuse?

Both can produce lower urinary tract symptoms (LUTS).

Shared symptoms can include:

• urinary frequency;
• urgency;
• nocturia;
• hesitancy;
• weak urinary stream;
• intermittent flow;
• straining;
• and a feeling of incomplete emptying.

Those symptoms alone do not establish either diagnosis.

Current EAU guidance emphasizes that male LUTS are multifactorial. They can arise from benign prostatic obstruction, bladder dysfunction, detrusor underactivity, overactive bladder, infection and other urological conditions.

Which symptoms are more characteristic of BPH-related obstruction?

BPH-related disease becomes more likely when the dominant pattern is chronic lower urinary tract dysfunction without an inflammatory or infectious illness.

Common complaints include:

• slow urinary stream;
• hesitancy before urine starts;
• intermittent flow;
• straining to void;
• post-void dribbling;
• incomplete emptying;
• increased daytime frequency;
• urgency;
• and waking at night to urinate.

However, none of these symptoms proves that benign prostate enlargement is the sole cause.

Which symptoms make prostatitis more likely?

Pain and infectious features help separate prostatitis from uncomplicated BPH.

Features that increase suspicion for prostatitis include:

• perineal pain;
• penile or scrotal pain;
• deep pelvic or prostate-region pain;
• painful ejaculation;
• pain or burning with urination;
• fever or chills in acute bacterial disease;
• a markedly tender prostate;
• and recurrent documented urinary infections in chronic bacterial prostatitis.

For the wider symptom pattern, see Prostatitis Symptoms.

Is pelvic pain typical of BPH?

Pelvic or perineal pain is not a defining feature of BPH.

A man can certainly have BPH and pelvic pain at the same time, but severe perineal, penile, ejaculatory or prostate-region pain should not automatically be blamed on prostate enlargement.

Other causes—including prostatitis, CP/CPPS, pelvic-floor dysfunction, infection and other pelvic conditions—may need evaluation.

Is fever typical of BPH?

No.

BPH does not normally produce fever, chills or systemic infection.

Fever in a man with urinary difficulty should change the clinical concern toward infection or another acute process.

Sudden fever combined with pelvic pain and urinary symptoms is particularly important because it can fit acute bacterial prostatitis.

Can both conditions cause urinary retention?

Yes, but through different mechanisms.

In BPH-related disease, urinary retention can occur when benign prostate enlargement and outlet resistance make it progressively difficult for the bladder to empty.

During acute bacterial prostatitis, inflammatory swelling around the prostatic urethra can rapidly impair urine flow.

Complete inability to urinate requires prompt medical assessment regardless of the suspected cause.

03. How Do Doctors Tell Prostatitis and BPH Apart?

The diagnostic question is different for each condition

For prostatitis, clinicians ask: Is there infection, inflammation or a chronic pelvic-pain syndrome?

For BPH-related disease, the question is closer to: Is benign prostate enlargement contributing to bothersome lower urinary tract symptoms or true bladder outlet obstruction?

Those questions require different evidence.

What tests are useful when prostatitis is suspected?

Depending on the clinical pattern, evaluation can include:

• history of pain, urinary symptoms and fever;
• urinalysis;
• midstream urine culture;
• careful digital rectal examination;
• blood testing in acute systemic infection;
• two-glass or four-glass prostate localization testing in selected chronic bacterial cases;
• pelvic-floor examination when CP/CPPS is suspected;
• and imaging when an abscess or another complication needs to be excluded.

The full process is explained in How Is Prostatitis Diagnosed?.

What tests are useful when BPH or benign obstruction is suspected?

Evaluation of male LUTS can include:

• medical history;
• validated symptom scoring;
• physical and digital rectal examination;
• urinalysis;
• post-void residual urine measurement;
• uroflowmetry;
• prostate imaging when prostate size will influence treatment;
• PSA when its result would change management or help estimate prostate volume/progression risk;
• and urodynamic pressure-flow testing in selected cases where the mechanism of obstruction remains uncertain.

EAU guidance emphasizes that prostate volume becomes particularly important when considering 5-alpha-reductase inhibitors or choosing an intervention.

Can a digital rectal examination tell the difference?

It can provide useful clues, but not a definitive diagnosis by itself.

During acute bacterial prostatitis, the gland can be markedly tender or swollen.

With BPH-related enlargement, the prostate may feel enlarged without the severe tenderness expected in an acute infection.

However, examination alone cannot reliably determine:

• whether urinary symptoms are caused by obstruction;
• whether bacteria are present;
• or whether chronic pelvic pain originates from the prostate, pelvic floor or another structure.

Does prostate size distinguish BPH from prostatitis?

Not reliably.

A large prostate supports benign prostate enlargement, particularly in the appropriate age and urinary-symptom context, but it does not prove that enlargement is causing all symptoms.

Likewise, a normal-sized prostate does not exclude prostatitis or CP/CPPS.

What does uroflowmetry show?

Uroflowmetry measures how urine flow changes while a patient voids.

A reduced maximum flow rate can support the presence of voiding dysfunction, but low flow is not specific to BPH.

It can also occur with:

• bladder outlet obstruction;
• urethral stricture;
• weak detrusor contraction;
• or inadequate bladder volume during the test.

For this reason, a slow flow curve should not automatically be translated into “the prostate is enlarged.”

What does post-void residual urine show?

Post-void residual urine estimates how much urine remains in the bladder after urination.

An elevated residual can occur when bladder emptying is impaired, but the test does not by itself establish whether the cause is benign prostate obstruction, weak bladder contraction or another condition.

Can PSA distinguish BPH from prostatitis?

No.

PSA is produced by prostate tissue and can be affected by several prostate conditions.

BPH and larger prostate volume can be associated with higher PSA, while active prostatitis can also temporarily raise PSA.

PSA therefore cannot be used as a simple “BPH versus prostatitis” test.

During active prostatitis, current EAU infection guidance advises against using PSA as a diagnostic test for the inflammatory episode because it does not provide useful information for establishing prostatitis.

For the specific relationship between infection and PSA, see Can Prostatitis Raise PSA?.

04. How Do Prostatitis and BPH Treatments Differ?

Why can alpha blockers be used for both conditions?

Alpha blockers are one reason patients sometimes assume the conditions are the same.

Medicines such as tamsulosin can reduce smooth-muscle tone around the prostate and bladder-neck region.

In men with BPH-related LUTS, alpha blockers are commonly used to improve urinary symptoms.

In CP/CPPS, current chronic-pelvic-pain guidance also supports alpha blockers in selected patients—particularly when voiding dysfunction is an important component.

The fact that one medicine can help symptoms in two conditions does not mean the conditions share the same underlying disease process.

Are 5-alpha-reductase inhibitors used for prostatitis?

Not as routine infection or chronic pelvic-pain treatment.

Medicines such as finasteride and dutasteride target androgen-dependent prostate growth and can reduce prostate volume over time in appropriately selected men with enlarged prostates.

That makes them primarily relevant to the BPH/BPE pathway rather than bacterial prostatitis.

For the distinction between the major BPH medication classes, see Alpha Blockers vs 5-Alpha-Reductase Inhibitors.

Are antibiotics used for BPH?

No, not simply because a man has BPH.

Antibiotics treat bacterial infection.

They are therefore central to treatment of acute and chronic bacterial prostatitis when clinically indicated, but they do not shrink benign hyperplastic tissue or correct benign prostatic obstruction.

The different bacterial and nonbacterial prostatitis treatments are explained in How Is Prostatitis Treated?.

Is pelvic-floor physical therapy a BPH treatment?

Not for benign prostate enlargement itself.

Pelvic-floor therapy can be useful when chronic pelvic pain includes muscle overactivity, myofascial trigger points or impaired pelvic-floor relaxation.

That makes it particularly relevant to selected men with CP/CPPS.

If a man has both BPH and pelvic-floor dysfunction, the conditions can require separate treatment strategies.

When are BPH procedures considered?

Procedures are generally considered when bothersome urinary symptoms or benign prostatic obstruction justify intervention, particularly when:

• medication provides insufficient benefit;
• complications develop;
• urinary retention becomes clinically important;
• or the patient prefers procedural treatment after shared decision-making.

Procedure selection depends on factors such as:

• prostate size;
• prostate anatomy;
• severity of obstruction;
• bleeding risk;
• sexual-function priorities;
• durability expectations;
• and local expertise.

The major options are compared in the BPH Procedures Guide.

Does prostate surgery treat CP/CPPS?

Not routinely.

Current EAU chronic-pelvic-pain guidance states that evidence does not support procedures such as TURP or radical prostatectomy as treatment for primary prostate pain syndrome simply to remove chronic pain.

This is clinically important because urinary symptoms and prostate-region pain can coexist.

A man should not undergo tissue-removing BPH surgery solely on the assumption that all chronic pelvic pain comes from benign prostate enlargement.

Can someone have BPH and prostatitis at the same time?

Yes.

These diagnoses are not mutually exclusive.

An older man with established benign prostate enlargement can develop a bacterial urinary infection or acute bacterial prostatitis.

A man with BPH can also develop CP/CPPS or another pelvic-pain condition.

When conditions coexist, treatment may need to address each problem separately.

Can BPH increase the risk of infection?

Significant bladder outlet obstruction and incomplete emptying can create urinary stasis, which can contribute to urinary complications in some men.

That does not mean BPH itself is an infection.

If infection occurs, it should be evaluated as a separate clinical problem.

What if urinary symptoms remain after prostatitis treatment?

Persistent urinary symptoms after the infectious episode has resolved should not automatically trigger more antibiotics.

Depending on the patient, clinicians may reassess:

• urine culture;
• prostate size;
• uroflowmetry;
• post-void residual urine;
• bladder function;
• pelvic-floor muscle function;
• and whether benign prostatic obstruction or another urinary condition is present.

What if pelvic pain remains after BPH treatment?

Improving obstruction does not guarantee that unrelated chronic pelvic pain will disappear.

Persistent perineal pain, penile pain, painful ejaculation or pelvic-floor tenderness after successful BPH treatment should prompt evaluation for another pain source rather than assuming the prostate remains mechanically obstructed.